The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Interim analysis of a phase II study of nivolumab/ipilimumab plus cabozantinib in patients with unresectable advanced melanoma.
 
Geoffrey Thomas Gibney
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Exicure; Genentech; HUYA Bioscience International; Iovance Biotherapeutics; Lyell Immunopharma; Merck; Novartis; Regeneron; Sapience Therapeutics
Research Funding - Exelixis (Inst); Lucerno Dynamics (Inst)
 
Andrew L Pecora
Employment - Celularity Inc; Cota Healthcare; Outcomes Matter Innovations (OMI); Regional Cancer Care Associates
Leadership - Celularity Inc; Cota Healthcare; Genetic testing cooperative (GTC); Regional Cancer Care Associates
Stock and Other Ownership Interests - Celularity Inc; Cota Healthcare; Genetic testing cooperative (GTC); Regional Cancer Care Associates
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Bristol-Myers Squibb
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb (Inst)
Patents, Royalties, Other Intellectual Property - Cd34 patents COTA patents
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Suthee Rapisuwon
Honoraria - General Dynamics Information Technology (GDIT)
Consulting or Advisory Role - Castle Biosciences
Research Funding - Bristol-Myers Squibb (Inst)
 
Kevin Chen
No Relationships to Disclose
 
Kellie Gardner
Speakers' Bureau - Exelixis; Genentech
 
Gayle Cramer
No Relationships to Disclose
 
Danielle Blair
No Relationships to Disclose
 
Amy Avergas
Employment - Exact Sciences (I)
Stock and Other Ownership Interests - Exact Sciences
 
Nicole Swanson
No Relationships to Disclose
 
Jaeil Ahn
Consulting or Advisory Role - KeifeRx; KeifeRx
 
Michael B. Atkins
Stock and Other Ownership Interests - Pyxis; Werewolf Pharma
Consulting or Advisory Role - Agenus; Asher Biotherapeutics; AstraZeneca; Aveo; Bristol-Myers Squibb; Cota Healthcare; Eisai; Ellipses Pharma; Exelixis; Fathom Biotechnology; Genentech; GlaxoSmithKline; Idera; Merck; Novartis; Oncorena; PACT Pharma; Pfizer; Pliant; Pyxis; Sanofi; Scholar Rock; Simcha Therapeutics; Surface Oncology; Takeda; Werewolf Pharma
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst)